The Discounted Cash Flow (DCF) valuation of TherapeuticsMD Inc (TXMD) is (2,204.03) USD. With the latest stock price at 1.18 USD, the upside of TherapeuticsMD Inc based on DCF is -186882.0%.
Based on the latest price of 1.18 USD and our DCF valuation, TherapeuticsMD Inc (TXMD) is a sell. selling TXMD stocks now will result in a potential gain of 186882.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.9% - 6.0% | 5.4% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (14,201.63) - (1,203.93) | (2,204.03) |
| Upside | -1203628.3% - -102128.0% | -186882.0% |